
Three studies reported here have confirmed that lornoxicam is effective in osteoarthritis and the ideal dose appears to be 12 mg daily. Overall, lornoxicam appears to be a useful drug in the treatment of both osteo- and rheumatoid arthritis, from the data presently available.
Adult, Male, Anti-Inflammatory Agents, Non-Steroidal, Middle Aged, Arthritis, Rheumatoid, Piroxicam, Double-Blind Method, Osteoarthritis, Humans, Female, Aged
Adult, Male, Anti-Inflammatory Agents, Non-Steroidal, Middle Aged, Arthritis, Rheumatoid, Piroxicam, Double-Blind Method, Osteoarthritis, Humans, Female, Aged
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
